[Dihydropyrimidine dehydrogenase deficiency screening for management of patients receiving a fluoropyrimidine: Results of two national practice surveys addressed to clinicians and biologists]

Autor: Loriot, Marie-Anne, Masskouri, Fadil, Carni, Paolo, Le Malicot, Karine, Seitz, Jean-François, Michel, Pierre, Legoux, Jean-Louis, Bouche, Olivier, André, Thierry, Faroux, Roger, Delaloge, Suzette, Malka, David, Guigay, Joël, Thariat, Juliette, Thomas, Fabienne, Barin-Le-Guellec, Chantal, Ciccolini, Joseph, Boyer, Jean-Christophe, Etienne-Grimaldi, Marie-Christine

Publikováno v: Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩
Bulletin du Cancer, 2019, 106 (9), pp.759-775. ⟨10.1016/j.bulcan.2019.04.013⟩

International audience; Dihydropyrimidine dehydrogenase (DPD) deficiency is the main cause of early severe toxicities induced by fluoropyrimidines (FP). The French Group of Clinical Oncopharmacology (GPCO)-Unicancer and the French Pharmacogenetics Ne

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a71787b5bcdf3dd56f31afec496e2a5b
https://hal.archives-ouvertes.fr/hal-02530344/file/S0007455119302255.pdf

[Current indications and ongoing clinical trials with CyberKnife stereotactic radiotherapy in France in 2009]

Autor: J, Thariat, G, Li, G, Angellier, S, Marchal, G, Palamini, G, Rucka, K, Bénézery, J, Castelli, R, Trimaud, H, Mammar, S, Marcie, J-P, Gérard, P-Y, Bondiau

Publikováno v: Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2009, 96 (9), pp.853-64. ⟨10.1684/bdc.2009.0942⟩

International audience; Image-guided frameless fractionated stereotactic radiotherapy can be performed with millimetric accuracy using the CyberKnife (Accuray Inc. Sunnyvale, USA) equipped with an integrated tracking system for intra- and extracrania

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ee79a516091c293547f98386d482b521
https://hal.archives-ouvertes.fr/hal-00442907